UMIN ID: UMIN000001809
Registered date:01/04/2009
To evaluate the efficacy and safety of KP-496NS for patients with perennial allergic rhinitis
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Perennial allergic rhinitis |
| Date of first enrollment | 2009/04/01 |
| Target sample size | 150 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Placebo KP-496NS 0.1% KP-496NS 0.3% |
Outcome(s)
| Primary Outcome | Nasal symptom score, rhinoscopic findings, side effects |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 16years-old |
|---|---|
| Age maximum | 65years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | (1) Patients having diseases that could interfere with assessment of treatment (2) Patients are/having recieved treatment for diseases that could interfere with assessment of treatment (3) Patients with bleeding tendency (4) Patients with problems in safety |
Related Information
| Primary Sponsor | KAKEN PHARMACEUTICAL CO., LTD. |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | KAKEN PHARMACEUTICAL CO., LTD. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | 28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo 113-8650, Japan Japan |
| Telephone | |
| Affiliation | KAKEN PHARMACEUTICAL CO., LTD. Clinical Development Department |
| scientific contact | |
| Name | Shunkichi Baba |
| Address | 1, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya City, Aichi, Japan, 467-8601 Japan |
| Telephone | |
| Affiliation | Graduated school of Medicine, Nagoya City University, emeritus professor Department of Otorhinolaryngology |